This research develops a rapid method for detecting antibiotic-resistant bacteria, indicating potential for precision medicine.
Accurate and timely detection of antibiotic-resistant bacteria is critical for controlling their spread and achieving precision medicine, necessitating the development of sensitive, contamination-free, and rapid approaches. Nucleic acid-cleaving DNAzymes have been extensively exploited in rapid and precise metal ion sensing; however, their featured response to single-stranded DNA/RNA has limited their application in accurate diagnosis of antibiotic-resistant bacteria, as double-stranded DNA (dsDNA) targets are typically used. To address this limitation, we innovatively developed an elongated DNAzyme-integrated asymmetric recombinase polymerase amplification, named EDA, for the one-tube and multiplexed detection of methicillin-resistant Staphylococcus aureus. Benefiting from the synergistic recognition and amplification capabilities of the cascaded recombinase polymerase amplification and DNAzyme catalytic reaction, single-bacterium-level sensitivity was achieved for both nuc and mecA genes in the fluorescent mode and detection limits as low as 10¹ CFU/mL were attained in the colorimetric detection mode. Furthermore, EDA exhibited excellent specificity, accuracy, and detection efficiency, featuring a sample-to-result time of 1 h. The constructed approach broadens the application scope of the DNAzyme and provides a contamination-free, multiplexed, and fully customizable detection platform for antibiotic-resistant bacteria.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: